Identification of extractable growth factors from small intestinal submucosa

Journal of Cellular Biochemistry

Volumn 67, Issue 4, 1997, Pages 478-491

  Voytik Harbin, Sherry L ^a   Brightman, Andrew O ^a   Kraine, Meredith R ^a   Waisner, Beverly ^a   Badylak, Stephen F ^a  

^a PURDUE UNIVERSITY   (United States)

Author keywords

Biomaterial; Cell proliferation; Extracellular matrix; Growth factors; Tissue repair

Indexed keywords

BASIC FIBROBLAST GROWTH FACTOR; DNA; EPIDERMAL GROWTH FACTOR; GROWTH FACTOR; GUANIDINE; MAGNESIUM CHLORIDE; PLATELET DERIVED GROWTH FACTOR; SODIUM CHLORIDE; THYMIDINE; TRANSFORMING GROWTH FACTOR BETA1; TRITIUM; UREA;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CELL PROLIFERATION; CELL STRAIN 3T3; CONTROLLED STUDY; DNA SYNTHESIS; EXTRACT; MOUSE; NONHUMAN; PRIORITY JOURNAL; SMALL INTESTINE; SUBMUCOSA; SWINE;

3T3 CELLS; ANIMALS; BIOLOGICAL ASSAY; CATTLE; CELL DIVISION; EPIDERMAL GROWTH FACTOR; FIBROBLAST GROWTH FACTOR 2; GROWTH SUBSTANCES; HUMANS; INTESTINAL MUCOSA; INTESTINE, SMALL; MICE; SWINE; TRANSFORMING GROWTH FACTOR BETA;

ANIMALIA; SUIDAE; SUS SCROFA; TRITIUM;

EID: 0030662701     PISSN: 07302312     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-4644(19971215)67:4<478::AID-JCB6>3.0.CO;2-P     Document Type: Article

References (42)

1. Aiken SW, Badylak SF, Toombs JP, Shelbourne KD, Hiles MC, Lantz GC, Van Sickle D (1994): Small intestinal submucosa as an intra-articular ligamentous graft material: A pilot study in dogs. Vet Comp Orthoped Trauma 7:124-128.
2. Aviezer D, Hecht D, Safran M, Eisinger M, David G, Yayon A (1994): Perlecan, basal lamina proteoglycan, promotes basic fibroblast growth factor-receptor binding, mitogenesis and angiogenesis. Cell 79:1005-1013.
3. Badylak SF (1993): Small intestinal submucosa (SIS): A biomaterial conducive to smart tissue remodeling. In Bell E (ed): "Tissue Engineering: Current Perspectives." Cambridge, MA: Burkhauser Publishers, pp 179-189.
4. Badylak SF, Voytik SL, Kokini K, Shelbourne KD, Klootwyck T, Kraine MR, Tulius R, Simmons C (1995): The use of xenogenic small intestinal submucosa as a biomaterial for achille's tendon repair in a dog model. J Biomed Mater Res 29:977-985.
5. Bashkin P, Doctrow S, Klagsbrun M, Svahn CM, Folkman J, Vlodavsky I (1989): Basic fibroblast growth factor binds to subendothelial extracellular matrix and is released by heparitinase and heparin-like molecules. Biochemistry 28:1737-1743.
6. Bell E (1995): Strategy for the selection of scaffolds for tissue engineering. Tissue Eng 1:163-179.
7. Brown K, Hendry I, Parish C (1995): Acidic and basic fibroblast growth factor bind with differing affinity to the same heparan sulfate proteoglycan on BALB/c 3T3 cells: Implications for potentiation of growth factor action by heparin. J Cell Biochem 58:6-14.
8. Cartlidge SA, Elder JB (1990): Transforming growth factor α and epidermal growth factor levels in normal human gastrointestinal mucosa. Br J Cancer 60:657-660.
9. Dallas SL, Miyazono K, Skerry TM, Mundy GR, Bonewald LF (1995): Dual role for the latent transforming growth factor-β binding protein in storage of latent TGF-β in the extracellular matrix and as a structural matrix protein. J Cell Biol 131:539-549.
10. Flaumenhaft R, Moscatelli D, Saksela O, Rifkin DB (1989): Role of extracellular matrix in the action of basic fibroblast growth factor: Matrix as a source of growth factor for long-term stimulation of plasminogen activator production and DNA synthesis. J Cell Phys 140:75-81.
11. Greenhalgh DG, Sprugel KH, Murray MJ, Ross R (1990): PDGF and FGF stimulate wound healing in the genetically diabetic mouse. Am J Path 136:1235-1246.
12. Hellman K, Picciolo G, Fox C (1994): Prospects for application of biotechnology-derived biomaterials. J Cell Biochem 56:210-224.
13. Hodde JP, Badylak SF, Brightman AO, Voytik-Harbin SL (1996): Glycosaminoglycan content of small intestinal submucosa: A bioscaffold for tissue replacement. Tissue Eng 2:209-217.
14. Howell JM (1996): Current and future trends in wound healing. Emerg Med Clin North Am 10:655-663.
15. Hubbell JA (1995): Biomaterials in tissue engineering. Bio/Technology 13:565-576.
16. Knapp PM, Lingeman JE, Siegel YI, Badylak SF, Demeter RJ (1994): Biocompatibility of small-intestinal submucosa in urinary tract augmentation cystoplasty graft and injectable suspension. J Endourol 8:125-130.
17. Langer R, Vacanti J, Vacanti C, Atala A, Freed L, Vunjak-Novakovic G (1995): Tissue engineering: Biomedical applications. Tissue Eng 1:151-161.
18. Lantz GC, Badylak SF, Hiles MC, Coffey AC, Geddes LA, Kokini K, Sandusky GE, Morff RJ (1993): Small intestinal submucosa as a vascular graft: A review. J Invest Surg 6:297-310.
19. Lysiak J, Hunt J, Pringle G, Lala P (1995): Localization of transforming growth factor-β and its natural inhibitor decorin in the human placenta and decidua throughout gestation. Placenta 16:221-231.
20. Marikovsky M, Breuing K, Liu PY, Eriksson E, Higashiyama S, Farber P, Abraham J, Klagsbrun M (1993): Appearance of heparin-binding EGF-like growth factor in wound fluid as a response to injury. Proc Natl Acad Sci USA 90:3889-3893.
21. Miao H, Fritz T, Esko J, Zimmerman J, Yayon A, Vlodavsky I (1995): Heparan sulfate primed on beta-D-xylosides restores binding of basic fibroblast growth factor. J Cell Biochem 57:173-184.
22. r. 25,000 heparin-binding protein from guinea pig brains is a high molecular weight form of basic fibroblast growth factor. Proc Natl Acad Sci USA 84:5778-5782.
23. Nice EC, Fabri L, Whitehead RH, James R, Simpson RJ, Burgess AW (1991): The major colonic cell mitogen extractable from colonic mucosa is an N-terminally extended form of basic fibroblast growth factor. J Biol Chem 266:14425-14430.
24. Ogawa Y, Schmidt DK, Dasch JR, Chang RJ, Glaser CB (1992): Purification and characterization of transforming growth factor-β2.3 and -ß1.2 heterodimers from bovine bone. J Biol Chem 267:2325-2328.
25. Ogawa Y, Seyedin M (1991): Purification of transforming growth factors β-1 and β-2 from bovine bone and cell culture assays. In: Ruoslahti E, Engrall E (eds): "Methods in Enzymology." San Diego, CA: Academic Press, Inc., pp 317-327.
26. Pierce GF, Mustoe TA, Altrock BW, Deuel TF, Thomason A (1991): Role of platelet-derived growth factor in wound healing. J Cell Biochem 45:319-326.
27. Prats H, Kaghad M, Prats AC, Klagsbrun M, Lélias JM, Liauzun P, Chalon P, Tauber JP, Amalric F, Smith JA, Caput D (1989): High molecular mass forms of basic fibroblast growth factor are initiated by alternative CUG codons. Proc Natl Acad Sci USA 86:1836-1840.
28. Prevel CD, Eppley BL, Summerlin DJ, Jackson JR, McCarty M, Badylak SF (1995): Small intestinal submucosa (SIS): Utilization for repair of rodent abdominal wall defects. Ann Plastic Surg 35:374-380.
29. Quaglino D, Jr., Nanney LB, Kennedy R, Davidson JM (1990): Transforming growth factor-β stimulates wound healing and modulates extracellular matrix gene expression in pig skin. Lab Invest 63:307-319.
30. Rapraeger AC, Guimond S, Krufka A, Olwin BB (1994): Regulation by heparan sulfate in fibroblast growth factor signaling. In: Ruoslahti E, Engrall E (eds): "Methods in Enzymology." San Diego, CA: Academic Press, Inc., pp. 219-239.
31. Reddi A (1994): Symbiosis of biotechnology and biomaterials: Applications in tissue engineering of bone and cartilage. J Cell Biochem 56:192-195.
32. Roberts AB, Sporn MB (1996): Transforming growth factor-β. In Clark RAF (ed): "The Molecular and Cellular Biology of Wound Repair." New York: Plenum Press, pp 275-308.
33. Roskelly CD, Srebrow A, Bissell MJ (1995): A hierarchy of ECM-mediated signalling regulates tissue-specific gene expression. Curr Opinion Cell Biol 7:736-747.
34. Schultz G, Totatori DS, Clark W (1991): EGF and TGFα in wound healing and repair. J Cell Biochem 45:346-352.
35. Taipale J, Miyazono K, Heldin CH, Keski-oja J (1994): Latent transforming growth factor-β1 associates to fibroblast extracellular matrix via latent TGFβ binding protein. J Cell Biol 124:171-181.
36. Takeuchi Y, Kodama Y, Matsumoto T (1994): Bone matrix decorin binds transforming growth factor-β and enhances its bioactivity. J Biol Chem 269:32634-32638.
37. ten Dijke P, Iwata KK (1989): Growth factors for wound healing. Bio/Technology 7:793-798.
38. Voytik-Harbin SL, Brightman AO, Waisner B, Lamar CH, Badylak SF (in press): Application and evaluation of the alamarBlue assay for cell growth and survival of fibroblasts. In Vitro Cell Dev Biol.
39. Wahl SM, Allen JB, Weeks BS, Wong HL, Klotman PE (1993): Transforming growth factor-β enhances integrin expression and type IV collagenase secretion in human monocytes. Proc Natl Acad Sci USA 90:4577-4581.
40. Werner S, Peters KG, Longaker MT, Fuller-Pace F, Banda MJ, Williams LT (1992): Large induction of keratinocyte growth factor expression in the dermis during wound healing. Proc Natl Acad Sci USA 89:6896-6900.
41. Yamaguchi Y, Mann DM, Ruoslahti E (1990): Negative regulation of transforming growth factor-β by the proteoglycan decorin. Nature 346:281-284.
42. Yannas I (1994): Applications of ECM analogs in surgery. J Cell Biochem 56:188-191.